Press Releases
ArteraAI and American Cancer Society Announce New Relationship
With the shared mission to improve the lives of those touched by cancer, both parties collaborate in the fight against the di [...]
Press Releases
ArteraAI Launches with $90 Million in Funding to Personalize Cancer Therapy With Multimodal AI
Funding supports the distribution of Artera’s flagship test in prostate cancer, as well as further test development across ca [...]
Press Releases
ArteraAI Announces Positive Results Around Its Multimodal Artificial Intelligence (MMAI) Prognostic Biomarker
Validated across six phase III randomized trials, the biomarker demonstrated the ability to help enable personalized, shared [...]
Press Releases
Our science was presented at the 2023 ASCO Genitourinary Cancers Symposium in San Francisco from February 16-18.
Patient-Level Data Meta-Analysis of a Multi-Modal Artificial Intelligence (MMAI) Prognostic Biomarker in High-Risk Prostate C [...]